Hospital Readmissions Among People With Sickle Cell Disease
In this cohort study with nationally representative data, patients with SCD had a significantly higher readmission risk than patients without SCD. Preventative, disease-modifying, and curative interventions are needed to reduce readmission risks and improve outcomes for patients with SCD.
Authors
- Herleen Rai (ORCID: https://orcid.org/0000-0001-6072-6098)
- Eshan U. Patel (ORCID: https://orcid.org/0000-0003-2174-5004)
- Evan M. Bloch (ORCID: https://orcid.org/0000-0001-8181-9517)
- Ruchika Goel (ORCID: https://orcid.org/0000-0001-9653-9905)
- Elizabeth P. Crowe (ORCID: https://orcid.org/0000-0003-1910-2800)
- Aaron A.R. Tobian (ORCID: https://orcid.org/0000-0002-0517-3766)
- Xianming Zhu (ORCID: https://orcid.org/0000-0002-3317-7449)
- Ping Yang (ORCID: https://orcid.org/0000-0002-8588-847X)
Institutions
- Johns Hopkins University (US)
- Southern Illinois University School of Medicine (US)
- Johns Hopkins Medicine (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-06-17
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.17974
- Citations
- 2
- Primary Topic
- Hemoglobinopathies and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 3.25
Funders
- Grifols
- National Institutes of Health